Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.1K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.1K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.3K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parent and professional experiences of a clinical trial of prenatal and postnatal stem cell therapy for severe osteogenesis imperfecta.

European journal of human genetics : EJHG·2026
Same author

Metabolic expenditure, neurodevelopment, and weight gain into early childhood after fetal growth restriction.

Scientific reports·2026
Same author

Placental apelin expression is low in early-onset fetal growth restriction but there is no association between maternal circulating apelin and pregnancy outcome.

Placenta·2026
Same author

Developmental Trends in Serum Iron, Transferrin, and Transferrin Saturation From Birth to 12 Months.

Acta paediatrica (Oslo, Norway : 1992)·2026
Same author

Surgeons' Perceptions on the Utility of a Conceptual Novel Force Sensor at the Surgeon-Tool Interface: Formative Interview Study.

JMIR formative research·2026
Same author

Rethinking urinary tract infections in women with abdominal pain in pregnancy: a prospective case-control study.

BMC pregnancy and childbirth·2026

Related Experiment Video

Updated: Oct 20, 2025

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
11:22

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

17.6K

Mesenchymal Stem Cell Therapy for Osteogenesis Imperfecta.

Cecilia Götherström1, Anna L David2, Lilian Walther-Jallow1

  • 1Departments of Clinical Science, Intervention and Technology (CLINTEC).

Clinical Obstetrics and Gynecology
|September 12, 2021
PubMed
Summary
This summary is machine-generated.

Mesenchymal stem cells (MSCs) show promise for treating osteogenesis imperfecta (OI) due to their regenerative capabilities. Clinical trials are evaluating the safety and efficacy of MSC therapy for severe OI cases.

More Related Videos

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
10:30

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications

Published on: December 8, 2016

10.2K
Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration
06:05

Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration

Published on: July 14, 2023

1.2K

Related Experiment Videos

Last Updated: Oct 20, 2025

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
11:22

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

17.6K
Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
10:30

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications

Published on: December 8, 2016

10.2K
Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration
06:05

Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration

Published on: July 14, 2023

1.2K

Area of Science:

  • Regenerative Medicine
  • Pediatric Orthopedics
  • Stem Cell Biology

Background:

  • Osteogenesis imperfecta (OI) is a genetic disorder characterized by brittle bones.
  • Current treatments for OI focus on symptom management, with limited options for addressing the underlying bone fragility.
  • Mesenchymal stem cells (MSCs) possess properties that make them potential therapeutic agents for OI.

Purpose of the Study:

  • To provide an overview of the rationale and background for using mesenchymal stem cells (MSCs) to treat osteogenesis imperfecta (OI).
  • To highlight the potential of MSCs as a clinical therapy for OI.
  • To discuss the ongoing clinical evaluation of MSC transplantation for severe OI.

Main Methods:

  • Review of existing animal studies and limited human clinical data on MSCs for OI treatment.
  • Discussion of the biological properties of MSCs, including migration, engraftment, differentiation, and paracrine effects.
  • Reference to the BOOSTB4 clinical trial assessing fetal MSC transplantation for severe OI.

Main Results:

  • MSCs demonstrate the ability to migrate, engraft, and differentiate into bone-forming cells.
  • Paracrine effects of MSCs contribute to tissue repair and regeneration.
  • Off-the-shelf MSCs offer a potentially widely available therapy due to their safety, differentiation potential, and low immunogenicity.

Conclusions:

  • Mesenchymal stem cells represent a promising experimental therapy for osteogenesis imperfecta.
  • Further clinical investigation, such as the BOOSTB4 trial, is crucial to establish the safety and efficacy of MSC transplantation for OI.
  • The unique properties of MSCs may offer a novel therapeutic strategy for improving bone health in individuals with OI.